Aldevron unveiled Alchemy
cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to support clinical applications. The company states the technology provides researchers with a faster, more efficient method to produce high-quality DNA templates. The company claims key benefits of the technology are faster turnaround, low endotoxin and other cell-derived impurities, and comparable quality control specifications.
Aldevron
The post Cell-Free DNA Manufacturing Technology appeared first on GEN - Genetic Engineering and Biotechnology News.

Aldevron
The post Cell-Free DNA Manufacturing Technology appeared first on GEN - Genetic Engineering and Biotechnology News.